Atrial fibrillation, clots, and stroke: the heart’s JNK2 as a target
Official title: Atrial fibrillation, Thrombogenesis, and Stroke: the central role of JNK2 with therapeutic potentials
Funded at Ohio State University · NIH-11465511 · Data updated 2026-11-12
This NIH grant explores how a heart protein called JNK2 may drive atrial fibrillation, blood clots, and stroke, and whether it could serve as a biomarker and new treatment approach.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project start | May 15, 2019 |
| Project end | April 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $807,274 |
| NIH project number | 2R01HL146744-05 |
| Project ID | NIH-11465511 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with atrial fibrillation or high stroke risk who may donate blood or tissue samples and participate in related biomarker studies.
✕Less likely to help
People without AF or stroke risk factors may not directly benefit.
What this research studies
If you have atrial fibrillation or are at risk for stroke, this research looks at how JNK2 in the heart influences blood clotting and stroke risk. The project builds on prior findings showing that JNK2 activity can travel in particles from the heart and make platelets more likely to form clots, potentially leading to stroke. Researchers will study the biological mechanisms in animal models and human cells, and test whether targeting JNK2 could both predict risk and reduce clotting. The goal is to identify new ways to prevent stroke in people with AF or similar conditions, especially as aging raises risk. This work could translate into better-guided therapies for preventing embolic events in patients with AF.
Why it matters
Potential benefit: If successful, the work could lead to new biomarkers and therapies that reduce stroke risk for people with atrial fibrillation.
How similar studies have gone: Preliminary human platelet studies and animal models support the approach, suggesting a promising direction but not yet proven in patients.
Where this research is happening
-
Ohio State University
Columbus, United States Active
Researchers
- Principal investigator: Ai, Xun — Ohio State University
- Study coordinator: Ai, Xun
Related research
Other NIH-funded projects on the same topics.
-
DECIDE-AF: a shared decision tool in your health portal to help prevent strokes in atrial fibrillation
A patient-friendly tool in your electronic health record helps you and your doctor choose the right way to prevent strokes if you have atrial fibrillation.
-
Advancing Shared Decision Making for Stroke Prevention in Atrial Fibrillation
Aims to combine data from three big trials to understand how decision aids help people with atrial fibrillation choose anticoagulation to prevent stroke, in a patient-centered way.
-
Personalized stroke risk prediction for atrial fibrillation patients using advanced data and models
Aims to create a personalized, easy-to-use tool that predicts stroke risk for people with atrial fibrillation using big health data and transparent machine-learning methods.
-
New AI approach to detect and predict atrial fibrillation after stroke
A patient-friendly AI-based method is being developed to spot atrial fibrillation early in people who have had a stroke, using wearable heart-rate signals.
-
Improving stroke prevention for patients with atrial fibrillation in emergency departments
This study is looking at how to help doctors in emergency rooms prescribe blood thinners better for patients with atrial fibrillation, which can help lower the risk of stroke.
-
Understanding Blood Thinners for Older Stroke Patients with Atrial Fibrillation
This project helps doctors choose the best blood thinner for older patients who have had a stroke and also have an irregular heartbeat called atrial fibrillation.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.